Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation
Circulation: Cardiovascular Interventions · 2026-07 · 19 (7)
DOI: 10.1161/circinterventions.125.015770 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-07. Verfasst von Cristina Aurigemma und 59 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy (C.A., M.L., F. Burzotta). Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Coronary Artery Disease, Myocardium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The best management of coronary artery disease in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) is debated. We investigated the clinical impact of the residual extent of myocardium at risk in patients undergoing TAVI. METHODS: Patients enrolled in the REVASC-TAVI (Management of Myocardial Revascularization in Patients Undergoing TAVI With Coronary Artery Disease) international multicenter registry were stratified according to the myocardium jeopardized by coronary artery disease using the British Cardiovascular Intervention Society Jeopardy Score (BCIS-JS) after a planned coronary revascularization. A planned revascularization included percutaneous coronary interventions performed before TAVI, during TAVI, or within 1 month after TAVI. The study population was divided according to the residual BCIS-JS (rBCIS-JS): patients with extensive residual myocardial at risk (rBCIS-JS >4 group) and patients without extensive residual myocardial at risk (rBCIS-JS ≤4 group). The primary study end point was the composite of all-cause death, nonfatal myocardial infarction, nonfatal stroke, and rehospitalization for heart failure at 2 years. RESULTS: Among the 2407 patients enrolled, 294 pairs of patients were selected by propensity matching and compared. At 2-year follow-up, the incidence of the primary end point was higher in patients with rBCIS-JS >4 compared with patients with rBCIS-JS ≤4 (37.5% versus 23.0%, P =0.004). A significantly lower rate of myocardial infarction was reported in patients with BCIS-JS ≤4 (8.2% versus 2.6%, P =0.011). At multivariate analysis, rBCIS-JS >4 (hazard ratio, 1.43 [95% CI, 1.11–1.84]; P =0.005) independently predicted 2-year major adverse cardiac and cerebrovascular events. CONCLUSIONS: In patients with concomitant coronary artery disease and severe aortic stenosis, the residual myocardial risk significantly affects TAVI outcomes. In particular, a rBCIS-JS >4 is associated with higher rates of major adverse cardiac and cerebrovascular events at 2 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy (C.A., M.L., F. Burzotta).
- Division of Cardiology, A.O.U. Policlinico G. Rodolico-San Marco, Catania, Italy (G.C.).
- Università degli Studi di Enna Kore, Italy (G.L., M. Barbanti).
- Bern University Hospital, Inselspital, University of Bern, Switzerland (T. Pilgrim, D. Tomii).
- Centro de investigación Biomédica en red-Enfermedades Cardiovasculares (CIBERCV). Hospital Clínico Universitario de Valladolid, Spain (I.J.A.S.).
- Department of Cardiology, Algemeen Ziekenhuis Turnhout, Belgium (O.D.B., P.N.).
ORCID-Profile: Cristina Aurigemma, Giuliano Costa, Giulia Laterra, Thomas Pilgrim, Ignacio J Amat Santos, Ole De Backer, Won-Keun Kim, Henrique Barbosa Ribeiro, Francesco Saia, Matjaz Bunc, Didier Tchetche, Philippe Garot, Flavio Luciano Ribichini, Yusuke Watanabe, Tullio Tesorio, Marco Tocci, Roberto Valvo, Sofia Sammartino, Mikko Savontaus, Hendrik Wienemann, Italo Porto, Caterina Gandolfo, Alessandro Iadanza, Markus Mach, Azeem Latib, Luigi Biasco, Federico De Marco, Valentina Frittitta, Elena Dipietro, Claudia Reddavid, Orazio Strazzieri, Federica Agnello, Alessandro Comis, Mariachiara Calì, Mohamed Abdel-Wahab, Giulio Giuseppe Stefanini, Daijiro Tomii, Philippe Nuyens, Alessandro S Bortone, Marco Zimarino, Sergio F Camara, Tullio Palmerini, Mateusz Orzalkiewicz, Klemen Steblovnik, Alexandre Gautier, Paolo Alberto Del Sole, Andrea Mainardi, Enrico Criscione, Fausto Biancari, Federico Zanin
Zitieren
APA
Aurigemma, C., Costa, G., Laterra, G., Pilgrim, T., Amat Santos, I. J., De Backer, O., Kim, W. K., Barbosa Ribeiro, H., Saia, F., Bunc, M., Tchetche, D., Garot, P., Ribichini, F. L., Mylotte, D., Watanabe, Y., Bedogni, F., Tesorio, T., Rheude, T., Sardella, G., …, & Zanin, F. (2026). Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation. Circulation: Cardiovascular Interventions, 19(7). https://doi.org/10.1161/circinterventions.125.015770
Vancouver
Aurigemma C, Costa G, Laterra G, Pilgrim T, Amat Santos IJ, De Backer O, et al. Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation. Circulation: Cardiovascular Interventions. 2026;19(7). doi:10.1161/circinterventions.125.015770
BibTeX
@article{Aurigemma2026,
author = {Aurigemma, Cristina and Costa, Giuliano and Laterra, Giulia and Pilgrim, Thomas and Amat Santos, Ignacio J and De Backer, Ole and Kim, Won-Keun and Barbosa Ribeiro, Henrique and Saia, Francesco and Bunc, Matjaz and Tchetche, Didier and Garot, Philippe and Ribichini, Flavio Luciano and Mylotte, Darren and Watanabe, Yusuke and Bedogni, Francesco and Tesorio, Tullio and Rheude, Tobias and Sardella, Gennaro and Tocci, Marco and Franzone, Anna and Valvo, Roberto and Sammartino, Sofia and Savontaus, Mikko and Wienemann, Hendrik and Porto, Italo and Gandolfo, Caterina and Iadanza, Alessandro and Mach, Markus and Latib, Azeem and Biasco, Luigi and Taramasso, Maurizio and De Marco, Federico and Frittitta, Valentina and Dipietro, Elena and Reddavid, Claudia and Strazzieri, Orazio and Agnello, Federica and Comis, Alessandro and Calì, Mariachiara and Abdel-Wahab, Mohamed and Stefanini, Giulio Giuseppe and Tomii, Daijiro and Nuyens, Philippe and Sondergaard, Lars and Bortone, Alessandro S and Zimarino, Marco and Camara, Sergio F and Palmerini, Tullio and Orzalkiewicz, Mateusz and Steblovnik, Klemen and Gautier, Alexandre and Del Sole, Paolo Alberto and Mainardi, Andrea and Lunardi, Mattia and Kawashima, Hideyuki and Criscione, Enrico and Cesario, Vincenzo and Biancari, Fausto and Zanin, Federico},
title = {Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {7},
doi = {10.1161/circinterventions.125.015770}
}
EUVIMED